TheHeleyCast - Episode 16 - Representative of District 33 John Talley
I sat down with my representative for my district here in Oklahoma, John Talley! We discussed issues in our home state, and also got to know who John really is! This was an amazing opportunity to sit down with him and get to know my own home states issues. Today everyone is so worried about the Federal Government. I wanted to change the pace and turn it back to our own states. I knew very little about my states government, this conversation really helped me understand Oklahoma's legislation. A huge thanks to John, himself for taking time out of his busy schedule to come onto the Podcast!Guys don't miss out on your chance to get a bottle of Carolyn's spice! the Promo runs till February 26 at 11:59 CST. The winner will be announced on all my social platforms at 12pm CST. Remember send in a simple joke to TheHeleyCast@yahoo.com for your chance to win!FB: heleythecomedianInsta: @forgot_my_heleysTwitter: @theheleycast
Ag Update: John Talley Talks Captive Insurance Basics
Join IRMI Chief Content Officer Joel Appelbaum and IRMI Captive and Risk Finance Product Manager Rachel Moir as they host John Talley, captive program manager for the Missouri Department of Commerce and Insurance. Mr. Talley breaks down what captives are really about and their applicability to agricultural insurance! Be sure to check out the other agribusiness resources that IRMI has to offer!
527: Creating Compounds to Treat Pain and Slow Tumor Growth - Dr. John Talley
People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers
Dr. John J. Talley is Co-Founder and Chief Scientific Officer of Euclises Pharmaceuticals, Inc. In addition, John is Co-Founder, Partner, and Vice President of Chemistry at Emmyon, Inc. John is an organic chemist who works to identify targets that can be modulated by chemicals. Currently, the two areas that John is focusing on are developing non-opioid treatments for acute and chronic pain and developing a new medicine that can be used with immune checkpoint inhibitors to slow or reverse tumor growth in cancer. In his free time, John enjoys cultivating vegetables and flowers in his garden, as well as growing indoor plants. Some of his other favorite activities include travel, camping with his family, and playing with his three cats. He received his BA in chemistry and science from Northern Iowa University and his PhD in organic chemistry from the University of Minnesota. Prior to joining the team at Euclises, John worked in various roles at Ironwood Pharmaceuticals, Pharmacia, Searle, Monsanto, and General Electric. John has received numerous honors and awards over the course of his career. He is co-inventor of seven marketed drugs, a named inventor on more than 215 U.S. drug patents, and a recipient of the prestigious PhRMA Foundation Discoverers Award. In our interview, John shares more about his life and research.